• Chugai has been recognized as a highly sustainable company and ranked first in the world as a pharmaceutical company
• Selected for three consecutive years in the “DJSI World,” comprised of the top seven sustainable pharmaceutical companies in the world
• Selected as “DJSI Asia Pacific” for the eighth time for five consecutive years

TOKYO, December 12, 2022 -- Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced that the company has been selected for three consecutive years as a constituent of “Dow Jones Sustainability Indices (DJSI) World,” the global version of DJSI, which is the world’s leading ESG investment index. Furthermore, Chugai has been selected as a constituent of “DJSI Asia Pacific,” the Asia-Pacific version, for the eighth time for five consecutive years.

“In our growth strategy “TOP I 2030,” we have set “Role model for the world” as one of three visions to become a top innovator in 2030. Chugai aims to become a company recognized for ESG initiatives through its business activities and lead in resolving social issues,” said Chugai’s President and CEO Dr. Osamu Okuda. “We are very pleased that our company’s sustainability disclosure and initiatives received the highest rating in the world in the pharmaceutical sector. Chugai will continue to create value for patients and society by leveraging innovation that only Chugai can provide and contribute to solving social issues and building a sustainable society through our business activities.”

DJSI is a leading ESG index developed by S&P Dow Jones Indices (USA) and is one of the main investment selection criteria for investors worldwide who are interested in corporate sustainability. Companies are selected annually as a constituent based on the sustainability assessment of corporate economic, environmental, and social aspects.

In the pharmaceutical sector of the “DJSI World,” the top seven sustainable companies have been selected as constituents, including Chugai. For the first time, Chugai received the world’s highest rating as the most sustainable company among global pharmaceutical companies. In total, 332 companies (including 36 Japanese companies) were selected for the DJSI World. Four companies, including Chugai, have been selected for “DJSI Asia Pacific.” Chugai significantly surpassed last year’s scores in areas such as Risk & Crisis Management, Information Security, Human Rights, Human Capital, Corporate Citizenship & Philanthropy, and Access to Healthcare, and received high marks overall.

The Company’s basic management policy is “creating shared value for Chugai and society” and aims to “realize advanced and sustainable patient-centric healthcare.” Chugai will continue dialogue with the stakeholders and contribute to the developing a sustainable society through our business activities.